Dear UroGPO Member,

UroGPO hosted an Overactive Bladder Medical Advisory Group meeting in New York City on Aug. 28, 2015, which consisted of 15 OAB physician champion specialists from a dozen leading urology practice members. Based on the feedback and initial market research, we set the meeting objectives as follows.

  • Discuss and use current evidence to support and implement consistent treatment patterns within private practice urology in order to create a relevant and prioritized direction to assist urologists in maintaining treatment of their OAB patients across the first, second and third line continuum of care.
  • Automate a clinical care algorithm for purpose of patient identification benchmarking, quality measures and market research.
  • Identify new tools for medication adherence to use to track patient treatments.

Below is a summation of the meeting presentations for your edification, review and future reference.

  • Dr. Sandy Siegel, CEO of Chesapeake Urology Associates discussed operationalizing the treatment of overactive bladder within Chesapeake Urology. Through this process, CUA focused on change management, connecting the right patient to the right doctor, creating consistency across providers, increasing medication compliance, advancing additional appropriate patients to second and third line treatments, and managing/educating patients at a higher level. Siegel shared Chesapeake Urology’s OAB protocol to give attendees a vision of what best practices might be implemented within urology groups after the New York meeting.
  • Dana Jacoby, from BSM Consulting, reviewed OAB market research and physician insights. From Jacoby’s research, most practices are challenged in the management and operations of the incontinence patient, regardless of setup, footprint, or navigator involvement. Jacoby shared an overview of the challenges urology groups face in managing incontinence and said that groups need consistency, data analytics, physician and staff management, and standard operating procedure development to be successful.
  • Hayden Bosworth, Ph.D., and Greg Muffler, CEO of Improved Patient Outcomes (IPO), highlighted IPO’s market research and ability to improve patient health outcomes through navigation and self-management by using evidence-based behavioral content and a multichannel patient engagement platform. Bosworth and Muffler gave educational insights around managing a chronic care patient and cross-pollenated case studies from other specialties and therapeutic conditions throughout their discussion. The IPO presentation focused on patient behavior algorithms, medication adherence and patient navigation strategies.
  • Jacoby and Steve Bass, CFO of Chesapeake Urology Associates, discussed OAB operations and governance, including patient triage, patient navigation, internal referrals and best practices. Through this presentation, Jacoby identified the best practices being utilized by attendees. She also presented five steps around how to create an effective OAB Center of Excellence.

As requested by attendees, a large portion of the meeting was dedicated to discussions about first, second and third line therapies, triage and operations. Throughout the meeting, UroGPO quantified and captured feedback for current and future reference. As we have done in the advanced prostate cancer space, the UroGPO team is working to create an OAB Guideline with operational best practices for distribution to our member groups and affiliates. We will be delivering this document at our upcoming National Urology Conference Oct. 9-10, 2015 in Charlotte, North Carolina.

Following the conference, we will also send the innovative guideline and operational overlay to all of our member practices.

The UroGPO team and I are excited about new partnerships with attendees, sponsors and existing UroGPO members. We are very enthusiastic about the future for our urology practice members, as well as our manufacturer partners. UroGPO is committed to creating innovative programs and strategies, similar to the OAB NYC meeting, to serve all parties moving forward.

Sincerely,

David Coury

Chief Executive Officer